---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-008310"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2024-05-15T23:59:59+00:00"
generated_at: "2026-06-01T22:37:50.608378+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Capricor shareholders approve doubling authorized shares to 100M and elect all nine director nominees

## Summary
- Amendment to increase authorized common shares from 50M to 100M approved (12.3M for, 8.7M against).
- All nine director nominees elected, including CEO Linda Marbán and Frank Litvack.
- Ratification of Rose, Snyder & Jacobs as auditor for FY 2024 approved (20.3M for).
- Non-binding advisory vote on executive compensation approved (9.2M for, 2.0M against).

## SEC filing metadata
- accession: 0001558370-24-008310
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2024-05-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/0001558370-24-008310-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/capr-20240514x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-008310
- JSON: https://secwatch.observer/filing/0001558370-24-008310.json
- Plain text: https://secwatch.observer/filing/0001558370-24-008310.txt

## Key facts
- Shareholder Votes
  CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Linda Marbán, Ph.D. as director at the 2024-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: rsuant to Section 12(b) of the Act: ​ Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market ​ ​ ​ ​ ​ Item 5.07 Submission of Matters of a Vote of Security Holders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/0001558370-24-008310-index.htm
- Shareholder Votes
  CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Michael Kelliher as director at the 2024-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: rsuant to Section 12(b) of the Act: ​ Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market ​ ​ ​ ​ ​ Item 5.07 Submission of Matters of a Vote of Security Holders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/0001558370-24-008310-index.htm
- Shareholder Votes
  CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Frank Litvack, M.D. as director at the 2024-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: rsuant to Section 12(b) of the Act: ​ Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market ​ ​ ​ ​ ​ Item 5.07 Submission of Matters of a Vote of Security Holders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/0001558370-24-008310-index.htm
- Shareholder Votes
  CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Paul Auwaerter, M.D. as director at the 2024-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: rsuant to Section 12(b) of the Act: ​ Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market ​ ​ ​ ​ ​ Item 5.07 Submission of Matters of a Vote of Security Holders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/0001558370-24-008310-index.htm
- Shareholder Votes
  CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Karimah Es Sabar as director at the 2024-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: rsuant to Section 12(b) of the Act: ​ Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market ​ ​ ​ ​ ​ Item 5.07 Submission of Matters of a Vote of Security Holders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/0001558370-24-008310-index.htm
- Shareholder Votes
  CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Earl M. Collier, Jr. as director at the 2024-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: rsuant to Section 12(b) of the Act: ​ Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market ​ ​ ​ ​ ​ Item 5.07 Submission of Matters of a Vote of Security Holders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/0001558370-24-008310-index.htm
- Shareholder Votes
  CAPRICOR THERAPEUTICS, INC. shareholders approved Election of Philip Gotwals, Ph.D. as director at the 2024-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: rsuant to Section 12(b) of the Act: ​ Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market ​ ​ ​ ​ ​ Item 5.07 Submission of Matters of a Vote of Security Holders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/0001558370-24-008310-index.htm
- Shareholder Votes
  CAPRICOR THERAPEUTICS, INC. shareholders approved Election of David B. Musket as director at the 2024-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: rsuant to Section 12(b) of the Act: ​ Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market ​ ​ ​ ​ ​ Item 5.07 Submission of Matters of a Vote of Security Holders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/0001558370-24-008310-index.htm
- Shareholder Votes
  CAPRICOR THERAPEUTICS, INC. shareholders approved Election of George W. Dunbar, Jr. as director at the 2024-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-05-14
  source text: rsuant to Section 12(b) of the Act: ​ Title of Each Class Trading Symbol(s) Name of Each Exchange on Which Registered Common Stock, par value $0.001 per share CAPR The Nasdaq Capital Market ​ ​ ​ ​ ​ Item 5.07 Submission of Matters of a Vote of Security Holders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1133869/000155837024008310/0001558370-24-008310-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.